NEKTAR THERAPEUTICS (NKTR) scores 31 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 0.18, representing a 100% premium to fair value. Quantitative score: 35/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.